AACAP Physician Scientist Program in Substance Abuse

AACAP 药物滥用医师科学家计划

基本信息

项目摘要

DESCRIPTION (provided by applicant): This is a competing renewal application for a NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12; PAR-07-346). The applicant Institution is the American Academy of Child and Adolescent Psychiatry (AACAP) under the leadership of Dr. Paula Riggs (Program Director/Principal Investigator). The majority of psychiatric and substance use disorders (SUD) begin during childhood or adolescence. Although the co-occurrence of psychiatric and substance use disorders is extremely common, the Institute of Medicine (2003) has identified a critical shortage of child and adolescent psychiatrists with dual training in developmental psychopathology and addiction. This shortage has contributed to broad research gaps and a lack of empirically-supported prevention and treatment. To address these gaps and the aims of this Initiative, we propose to support the career development of six child and adolescent psychiatrists who are committed to research independence in clinically relevant areas of drug abuse and addiction. In order to accomplish this aim, it will be necessary to expand the network of senior investigators and addiction research centers and training opportunities for young investigators, which is the second aim of the Initiative. During two previous funding periods from 1998-2004 (Leventhal.Pl) and 2005-2009 (Riggs, PI), the AACAP Physician Scientist Program in Substance Abuse (K12) has significantly increased the number of child and adolescent psychiatrists with addiction research careers and expanded the network of mentors and addiction research training centers by partnering with NIDA's Clinical Trials Network as a training platform for the AACAP K12. The commitment, environment and resources of the AACAP make it an ideal institutional "home" for the K12. With more than 90% of the child and adolescent psychiatrists in the country as members, the AACAP is well-positioned to facilitate the speed at which research is translated into practice. If funded, we propose to continue building on the success of our two previous AACAP K12 Awards to address the aims of this NIDA Initiative. PUBLIC HEALTH RELEVANCE: Increasing the number of child and adolescent psychiatrists with dual training in mental health and addiction research will provide them with the skills necessary to develop basic research advances in prevention and treatment and improve patient care.
描述(由申请人提供):这是NIDA指导临床科学家药物滥用和成瘾发展计划奖(K12; PAR-07-346)的竞争性续期申请。申请机构是美国儿童和青少年精神病学学会(AACAP),由Paula Riggs博士(项目主任/首席研究员)领导。大多数精神和物质使用障碍(SUD)开始于儿童或青少年时期。虽然精神疾病和药物使用障碍的共同发生极为普遍,但医学研究所(2003年)发现,在发育精神病理学和成瘾方面接受过双重培训的儿童和青少年精神病学家严重短缺。这种短缺造成了广泛的研究差距和缺乏经验支持的预防和治疗。为了解决这些差距和该倡议的目标,我们建议支持六名儿童和青少年精神病学家的职业发展,他们致力于在药物滥用和成瘾的临床相关领域进行独立研究。为了实现这一目标,有必要扩大高级研究人员和成瘾研究中心的网络,并为年轻研究人员提供培训机会,这是该倡议的第二个目标。在1998-2004年(Leventhal.Pl)和2005-2009年(Riggs, PI)的前两个资助期间,AACAP药物滥用医师科学家计划(K12)显著增加了从事成瘾研究职业的儿童和青少年精神病学家的数量,并通过与NIDA的临床试验网络合作,扩大了导师网络和成瘾研究培训中心,作为AACAP K12的培训平台。AACAP的承诺、环境和资源使其成为K12理想的机构“家”。美国90%以上的儿童和青少年精神科医生都是AACAP的成员,因此AACAP在加快研究成果转化为实践方面处于有利地位。如果获得资助,我们建议在前两个AACAP K12奖项的成功基础上继续努力,以实现这一NIDA倡议的目标。与公共卫生的关系:增加在心理健康和成瘾研究方面受过双重培训的儿童和青少年精神病医生的人数,将使他们具备必要的技能,在预防和治疗方面取得基础研究进展,并改善病人护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paula DeGraffenreid Riggs其他文献

Paula DeGraffenreid Riggs的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paula DeGraffenreid Riggs', 18)}}的其他基金

Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    8322985
  • 财政年份:
    2008
  • 资助金额:
    $ 45.99万
  • 项目类别:
Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    7840535
  • 财政年份:
    2008
  • 资助金额:
    $ 45.99万
  • 项目类别:
Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    7367685
  • 财政年份:
    2008
  • 资助金额:
    $ 45.99万
  • 项目类别:
Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    8278586
  • 财政年份:
    2008
  • 资助金额:
    $ 45.99万
  • 项目类别:
Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    8077427
  • 财政年份:
    2008
  • 资助金额:
    $ 45.99万
  • 项目类别:
Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    7675467
  • 财政年份:
    2008
  • 资助金额:
    $ 45.99万
  • 项目类别:
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION
物质依赖青少年——治疗抑郁症的影响
  • 批准号:
    6653679
  • 财政年份:
    2000
  • 资助金额:
    $ 45.99万
  • 项目类别:
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE
落基山区域临床试验节点
  • 批准号:
    7029121
  • 财政年份:
    2000
  • 资助金额:
    $ 45.99万
  • 项目类别:
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE
落基山区域临床试验节点
  • 批准号:
    6889322
  • 财政年份:
    2000
  • 资助金额:
    $ 45.99万
  • 项目类别:
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION
物质依赖青少年——治疗抑郁症的影响
  • 批准号:
    6646416
  • 财政年份:
    2000
  • 资助金额:
    $ 45.99万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 45.99万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.99万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 45.99万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.99万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 45.99万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 45.99万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.99万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 45.99万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 45.99万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.99万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了